Note: Ingredients listed on restricted chemical lists
EC/CAS
103-90-2
Name of the chemical
N-(4-hydroxyphenyl) acetamide
Concentration
N/A
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
General Information
Revision date
2021-12-02
Product name
EXCEDRIN TABLETS AND CAPLETS
Product Synonyms
CIBALENAA * EXCEDRIN CAPLETS * EXCEDRIN EXTRA FUERTE * EXCEDRIN EXTRA
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline Canada
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Section 2
Physical hazards
Not classified.
Health hazards
Acute toxicity, oral Category 4 Skin corrosion/irritation Category 2 Serious eye damage/eye irritation Category 2
Environmental hazards
Hazardous to the aquatic environment, acute Category 3 Hazardous to the aquatic environment, Category 3
Signal word
Warning
Hazard statements
Harmful if swallowed. Causes skin irritation. Causes serious eye irritation. Harmful to aquatic life. Harmful to aquatic life with long lasting effects.
Prevention
Wash thoroughly after handling. Do not eat, drink or smoke when using this product. Avoid release to the environment. Wear eye protection/face protection. Wear protective gloves.
Response
IF SWALLOWED: Call a POISON CENTRE/doctor/ if you feel unwell. Rinse mouth. IF ON SKIN: Wash with plenty of water. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Specific treatment (see on this label). If skin irritation occurs Get medical advice/attention. If eye irritation persists Get medical advice/attention. Take off contaminated clothing and wash it before reuse.
Storage
Not available.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
2.3 Other hazards
None known.
Additional information
14.77 % of the mixture consists of component(s) of unknown acute oral toxicity. 99.2763 % of the mixture consists of component(s) of unknown acute dermal toxicity. 15.8163 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 15.8163 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
